Clinical Trial Update: Analysis of Expression of Specific Markers in Hepatocellular Carcinoma

View source ↗

Summary

This completed clinical trial analyzes the expression of specific biomarkers in hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatocellular Carcinoma | Status: COMPLETED